HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Srikanth R Polusani Selected Research
Srikanth R Polusani Research Topics
Disease
6
Neoplasms (Cancer)
01/2021 - 01/2013
2
Obesity
01/2021 - 01/2019
1
Metabolic Syndrome (Dysmetabolic Syndrome X)
01/2021
1
Multiple Myeloma
01/2021
1
Dyslipidemias (Dyslipidemia)
01/2021
1
Hypertension (High Blood Pressure)
01/2021
1
Insulin Resistance
01/2021
1
Atherosclerosis
01/2021
1
Squamous Cell Carcinoma of Head and Neck
05/2019
1
Mitochondrial Diseases (Mitochondrial Disease)
05/2019
1
Facial Pain (Myofacial Pain)
05/2019
1
Endometrial Neoplasms (Endometrial Cancer)
01/2019
1
Wounds and Injuries (Trauma)
12/2016
1
Antley-Bixler Syndrome Phenotype
01/2013
1
Carcinogenesis
01/2013
Drug/Important Bio-Agent (IBA)
3
capsazepine
IBA
06/2019 - 01/2019
2
Connexin 43 (Connexin43)
IBA
01/2019 - 01/2013
1
Lipoproteins (Lipoprotein)
IBA
01/2021
1
LDL Lipoproteins (beta Lipoproteins)
IBA
01/2021
1
LDL Cholesterol
IBA
01/2021
1
Proteasome Inhibitors
IBA
01/2021
1
oxidized low density lipoprotein
IBA
01/2021
1
Boronic Acids
IBA
01/2021
1
Calcium
IBA
05/2019
1
Transient Receptor Potential Channels
IBA
05/2019
1
DNA (Deoxyribonucleic Acid)
IBA
01/2019
1
Adipokines
IBA
01/2019
1
Proteins (Proteins, Gene)
FDA Link
12/2016
1
RNA (Ribonucleic Acid)
IBA
12/2016
1
Cadherins (E-Cadherin)
IBA
12/2016
1
Connexins
IBA
01/2013
1
NADPH-Ferrihemoprotein Reductase (Cytochrome P450 Reductase)
IBA
01/2013
1
Enzymes
IBA
01/2013
Therapy/Procedure
2
Therapeutics
01/2021 - 05/2019